Laiyemo Adeyinka O, Murphy Gwen, Sansbury Leah B, Wang Zhuoqiao, Albert Paul S, Marcus Pamela M, Schoen Robert E, Cross Amanda J, Schatzkin Arthur, Lanza Elaine
Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute, Bethesda, Maryland 20892, USA.
Clin Gastroenterol Hepatol. 2009 Feb;7(2):192-7. doi: 10.1016/j.cgh.2008.08.031. Epub 2008 Sep 3.
Recent studies have suggested that some hyperplastic polyps may be associated with an increased risk of colorectal cancer. Prospective information on the risk of adenoma recurrence associated with hyperplastic polyps is limited. We sought to investigate whether the coexistence of hyperplastic polyps with adenomas increases the risk of adenoma recurrence.
We used unconditional logistic regression models to examine the association between baseline hyperplastic polyps and subsequent adenoma recurrence during a 3-year follow-up evaluation, among 1637 participants in the Polyp Prevention Trial.
A total of 437 participants (26.7%) had hyperplastic polyps coexisting with adenomas at baseline. Of these, 132 (30.2%) had at least one hyperplastic polyp in the proximal colon, whereas 305 (69.8%) had only distal hyperplastic polyps. When compared with subjects without any hyperplastic polyps at baseline, there was no statistically significant association between the presence of baseline hyperplastic polyps and recurrence of any adenoma (odds ratio [OR], 1.19; 95% confidence interval [CI], 0.94-1.51) or advanced adenoma (OR, 1.25; 95% CI, 0.78-2.03). Also, there was no association between hyperplastic polyp location and adenoma recurrence (OR, 1.01; 95% CI, 0.69-1.48) for any proximal hyperplastic polyp (OR, 1.26; 95% CI, 0.96-1.65) and for distal hyperplastic polyps.
The coexistence of hyperplastic polyps with adenomas, irrespective of location, does not confer an increased risk of adenoma recurrence beyond that of adenomas alone within 3 years of follow-up evaluation. Prospective long-term studies on adenoma recurrence risk associated with hyperplastic polyps in screening populations are needed.
近期研究表明,一些增生性息肉可能与结直肠癌风险增加有关。关于增生性息肉相关腺瘤复发风险的前瞻性信息有限。我们试图研究增生性息肉与腺瘤并存是否会增加腺瘤复发风险。
我们使用无条件逻辑回归模型,在息肉预防试验的1637名参与者中,研究基线增生性息肉与3年随访评估期间后续腺瘤复发之间的关联。
共有437名参与者(26.7%)在基线时增生性息肉与腺瘤并存。其中,132名(30.2%)在近端结肠至少有一个增生性息肉,而305名(69.8%)只有远端增生性息肉。与基线时无任何增生性息肉的受试者相比,基线增生性息肉的存在与任何腺瘤复发(优势比[OR],1.19;95%置信区间[CI],0.94 - 1.51)或高级别腺瘤复发(OR,1.25;95%CI,0.78 - 2.03)之间无统计学显著关联。此外,对于任何近端增生性息肉(OR,1.26;95%CI,0.96 - 1.65)和远端增生性息肉,增生性息肉位置与腺瘤复发之间也无关联(OR,1.01;95%CI,0.69 - 1.48)。
增生性息肉与腺瘤并存,无论其位置如何,在随访评估的3年内,除了腺瘤本身的复发风险外,并不会增加腺瘤复发风险。需要对筛查人群中与增生性息肉相关的腺瘤复发风险进行前瞻性长期研究。